SARAVANAKUMAR SUNDARARAJAN
Erode Sengunthar Engineering College, Lifecell International Pvt Ltd, University of Madras, Jeppiaar Engineering College, Madras Diabetes Research Foundation
0009-0004-9572-2950
About
Associate Professor in the Department of Biotechnology with strong academic, research, and industrial expertise in Molecular Biology, Genetic Diagnostics, and Biomedical Research. Experienced in handling undergraduate and postgraduate subjects including Biochemistry, Molecular Biology, Genetic Engineering, Cell Biology, Bioinformatics, Genomics and Proteomics, Protein Engineering, and Tissue Engineering. Possess extensive hands-on expertise in molecular genetics, genomic analysis, clinical diagnostics, Sanger sequencing, Chromosomal Microarray, MLPA, RT-PCR, mutation profiling, molecular cloning, and biomarker discovery. Skilled in conducting interdisciplinary research related to diabetes, atherosclerosis, nephropathy, and genetic disorders, with multiple publications in reputed international journals. Dedicated to teaching, research mentorship, and advancing innovation in biotechnology and molecular medicine.
Employment
-
Erode Sengunthar Engineering College Associate Professor2025 - Present
-
Lifecell International Pvt Ltd Assistant Manager and Researcher2022 - 2025
-
Madras Diabetes Research Foundation Research Scholar2013 - 2022
Education
-
University of Madras PhD2015 - 2023
-
Jeppiaar Engineering College M.Tech2011 - 2013
-
Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology B.Tech2007 - 2011
Projects & Funding
Projects & funding information is unavailable.
Publications (9)
- Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats Save
- IDF21-0158 Aegeline mitigates high glucose induced renal cell fibrosis by alleviating ROS generation & augmenting hydrogen sulphide Save
- IDF21-0159 Asymmetric Dimethylarginine and 20-Hydroxyeicosatetraenoic Acid – A lethal combo in diabetic kidney disease Save
- IDF21-0406 Genetic variants in the Carnosine-Carnosinase system and their impact on diabetic nephropathy Save
- Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin Save
- Decreased Sestrin levels in patients with type 2 diabetes and dyslipidemia and their association with the severity of atherogenic index Save
- Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway Save
- Sestrin2 regulates monocyte activation through AMPK-mTOR nexus under high-glucose and dyslipidemic conditions Save
- Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury Save